1
/
of
0
Cilatin (Cisplatin)
Cilatin (Cisplatin)
Regular price
₱1,540.00 PHP
Regular price
Sale price
₱1,540.00 PHP
Taxes included.
Quantity
Couldn't load pickup availability
Cilatin (Cisplatin) is a platinum-based chemotherapy medication used to treat various solid tumors and cancers. This cytotoxic agent works by binding to DNA and creating cross-links that inhibit DNA replication and transcription, leading to cancer cell death. Cisplatin remains one of the most effective and widely used chemotherapy drugs in oncology.
Cilatin is indicated for the treatment of testicular cancer, ovarian cancer, bladder cancer, head and neck cancers, lung cancer (both small cell and non-small cell), cervical cancer, and other solid tumors as part of combination chemotherapy regimens. It is often used as a first-line treatment for certain malignancies and is frequently combined with other chemotherapy agents to enhance therapeutic outcomes.
Important contraindications include hypersensitivity to cisplatin or other platinum compounds, pre-existing renal impairment due to nephrotoxicity risk, hearing impairment due to ototoxicity, bone marrow suppression, and pregnancy or breastfeeding due to teratogenic effects. Patients with compromised kidney function or existing hearing loss require careful evaluation before treatment initiation.
Dosage and treatment schedules are determined by your oncologist based on cancer type, stage, patient age, overall health, and kidney function. Cisplatin is administered under strict medical supervision, typically via intravenous infusion in clinical settings. Regular monitoring of kidney function, hearing, and blood counts is essential during treatment.
Do not use this medication without proper medical consultation and prescription from a qualified healthcare provider. Cisplatin carries significant potential for serious side effects and requires careful patient selection, dosing adjustments, and ongoing clinical monitoring throughout the treatment course.
Cilatin is indicated for the treatment of testicular cancer, ovarian cancer, bladder cancer, head and neck cancers, lung cancer (both small cell and non-small cell), cervical cancer, and other solid tumors as part of combination chemotherapy regimens. It is often used as a first-line treatment for certain malignancies and is frequently combined with other chemotherapy agents to enhance therapeutic outcomes.
Important contraindications include hypersensitivity to cisplatin or other platinum compounds, pre-existing renal impairment due to nephrotoxicity risk, hearing impairment due to ototoxicity, bone marrow suppression, and pregnancy or breastfeeding due to teratogenic effects. Patients with compromised kidney function or existing hearing loss require careful evaluation before treatment initiation.
Dosage and treatment schedules are determined by your oncologist based on cancer type, stage, patient age, overall health, and kidney function. Cisplatin is administered under strict medical supervision, typically via intravenous infusion in clinical settings. Regular monitoring of kidney function, hearing, and blood counts is essential during treatment.
Do not use this medication without proper medical consultation and prescription from a qualified healthcare provider. Cisplatin carries significant potential for serious side effects and requires careful patient selection, dosing adjustments, and ongoing clinical monitoring throughout the treatment course.